SEC61: a potential therapeutic target in transplantation

Area of Science:

• Immunology
• Cell Biology
• Transplantation Science

Background:

• The SEC61 translocon complex is crucial for protein translocation and calcium homeostasis.
• It influences immune regulation, including antigen presentation and cytokine secretion.
• SEC61 acts as an endoplasmic reticulum calcium-leak channel, impacting cellular stress responses.

Purpose of the Study:

• To review the multifaceted roles of SEC61 in kidney transplant immunobiology.
• To explore the therapeutic potential of SEC61 modulation in kidney transplantation.
• To examine SEC61's link to protein secretion, calcium homeostasis, and immune regulation.

Main Methods:

• Review of existing literature on SEC61 function in cellular processes and transplantation.
• Analysis of preclinical evidence for SEC61 inhibition's immunomodulatory and cytoprotective effects.
• Examination of emerging clinical data from oncology trials regarding SEC61 inhibitors.

Main Results:

• SEC61 regulates critical immune processes like antigen cross-presentation and T cell migration.
• Ischemia-reperfusion injury involves SEC61-mediated calcium efflux, leading to ER stress and tubular injury.
• Pharmacological SEC61 inhibition shows potential for reduced immune responses and cytoprotection.

Conclusions:

• SEC61 is a promising therapeutic target for modulating immune responses in kidney transplantation.
• Further validation in transplant-specific models is needed to confirm therapeutic efficacy and safety.
• SEC61 inhibition may offer novel strategies for improving transplant outcomes.